Latest News about LLY
Recent news which mentions LLY
3 Unstoppable Stocks to Buy Right Now
Today 6:56 EST
From Motley Fool
Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'
December 08, 2023
From Benzinga
Pharma Giant Eli Lilly's Shareholder Bonanza: Announces Hefty 15% Dividend Hike For Q1
December 08, 2023
Tickers
LLY
From Benzinga
From Motley Fool
Challenging the Magnificent 7: 3 Stocks on the Rise
December 08, 2023
From InvestorPlace
From MarketWatch
Better Large-Cap Growth Fund: Schwab U.S. Large-Cap Growth or Vanguard Growth Index Fund?
December 07, 2023
From Motley Fool
Should You Buy Eli Lilly Stock Now or Wait for a Dip?
December 07, 2023
Tickers
LLY
From Motley Fool
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?
December 07, 2023
From Motley Fool
Walmart seems to have changed its view of weight-loss drugs
December 06, 2023
From MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
From Benzinga
No more exercising? President RFK Jr.? Here’s one bank’s outrageous predictions for 2024
December 05, 2023
From MarketWatch
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
December 04, 2023
From Benzinga
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market
December 04, 2023
From Benzinga
1 Monster Dividend Stock Growth Investors Should Load Up On Right Now
December 04, 2023
Tickers
LLY
From Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
From Motley Fool
From Benzinga
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
December 04, 2023
From MarketWatch
3 No-Brainer Growth Stocks to Buy in December
December 03, 2023
From Motley Fool
An Important History Lesson for Gene-Editing Investors
December 02, 2023
From Motley Fool
Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?
December 02, 2023
From Motley Fool
5 Top Stocks to Buy Before 2024
December 02, 2023
From Motley Fool
Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers
December 01, 2023
From Benzinga
Weight Loss Drugs - Novo Nordisk A Primary Beneficiary In Obesity Space Currently Controlled By Two Players, Says Analyst
December 01, 2023
From Benzinga
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.